117 related articles for article (PubMed ID: 22704783)
1. Anti-angiogenic effects of lycopene through immunomodualtion of cytokine secretion in human peripheral blood mononuclear cells.
Huang CS; Chuang CH; Lo TF; Hu ML
J Nutr Biochem; 2013 Feb; 24(2):428-34. PubMed ID: 22704783
[TBL] [Abstract][Full Text] [Related]
2. Lycopene inhibits angiogenesis both in vitro and in vivo by inhibiting MMP-2/uPA system through VEGFR2-mediated PI3K-Akt and ERK/p38 signaling pathways.
Chen ML; Lin YH; Yang CM; Hu ML
Mol Nutr Food Res; 2012 Jun; 56(6):889-99. PubMed ID: 22707264
[TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenic effects and mechanisms of polysaccharides from Antrodia cinnamomea with different molecular weights.
Yang CM; Zhou YJ; Wang RJ; Hu ML
J Ethnopharmacol; 2009 Jun; 123(3):407-12. PubMed ID: 19501273
[TBL] [Abstract][Full Text] [Related]
4. Effects of lycopene and apigenin on human umbilical vein endothelial cells in vitro under angiogenic stimulation.
Sahin M; Sahin E; Gümüşlü S
Acta Histochem; 2012 Feb; 114(2):94-100. PubMed ID: 21474164
[TBL] [Abstract][Full Text] [Related]
5. γ-Tocotrienol inhibits angiogenesis of human umbilical vein endothelial cell induced by cancer cell.
Li Y; Sun WG; Liu HK; Qi GY; Wang Q; Sun XR; Chen BQ; Liu JR
J Nutr Biochem; 2011 Dec; 22(12):1127-36. PubMed ID: 21292465
[TBL] [Abstract][Full Text] [Related]
6. Lycopene inhibits angiogenesis in human umbilical vein endothelial cells and rat aortic rings.
Elgass S; Cooper A; Chopra M
Br J Nutr; 2012 Aug; 108(3):431-9. PubMed ID: 22142444
[TBL] [Abstract][Full Text] [Related]
7. Anti-angiogenic activity of Ipomoea obscura extract and Ipobscurine-A.
Hamsa TP; Kuttan G
Immunopharmacol Immunotoxicol; 2011 Sep; 33(3):488-97. PubMed ID: 21058930
[TBL] [Abstract][Full Text] [Related]
8. Anti-angiogenic effect of Tanshinone IIA involves inhibition of matrix invasion and modification of MMP-2/TIMP-2 secretion in vascular endothelial cells.
Tsai MY; Yang RC; Wu HT; Pang JH; Huang ST
Cancer Lett; 2011 Nov; 310(2):198-206. PubMed ID: 21788102
[TBL] [Abstract][Full Text] [Related]
9. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
Zhong ZF; Hoi PM; Wu GS; Xu ZT; Tan W; Chen XP; Cui L; Wu T; Wang YT
J Ethnopharmacol; 2012 Jun; 141(2):721-7. PubMed ID: 21911050
[TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic effects of a nutrient mixture on human umbilical vein endothelial cells.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2005 Dec; 14(6):1399-404. PubMed ID: 16273231
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of Physalis angulata on tumor metastasis and angiogenesis.
Hseu YC; Wu CR; Chang HW; Kumar KJ; Lin MK; Chen CS; Cho HJ; Huang CY; Huang CY; Lee HZ; Hsieh WT; Chung JG; Wang HM; Yang HL
J Ethnopharmacol; 2011 Jun; 135(3):762-71. PubMed ID: 21515352
[TBL] [Abstract][Full Text] [Related]
12. Soluble interleukin-6 receptor alpha inhibits the cytokine-Induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture.
Matsumiya T; Imaizumi T; Fujimoto K; Cui X; Shibata T; Tamo W; Kumagai M; Tanji K; Yoshida H; Kimura H; Satoh K
Exp Cell Res; 2001 Sep; 269(1):35-41. PubMed ID: 11525637
[TBL] [Abstract][Full Text] [Related]
13. [In vitro anti-angiogenic action of lambda-carrageenan oligosaccharides].
Chen HM; Yan XJ; Wang F; Lin J; Xu WF
Yao Xue Xue Bao; 2007 Jun; 42(6):595-600. PubMed ID: 17702394
[TBL] [Abstract][Full Text] [Related]
14. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.
Gao W; Jin K; Lan H; Han N; Cao F; Teng L
Hepatogastroenterology; 2012; 59(120):2543-7. PubMed ID: 22534543
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
[TBL] [Abstract][Full Text] [Related]
16. Benzo[a]pyrene inhibits angiogenic factors-induced alphavbeta3 integrin expression, neovasculogenesis, and angiogenesis in human umbilical vein endothelial cells.
Li CH; Cheng YW; Hsu YT; Hsu YJ; Liao PL; Kang JJ
Toxicol Sci; 2010 Dec; 118(2):544-53. PubMed ID: 20876236
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human interleukin-24 suppresses gastric carcinoma cell growth in vitro and in vivo.
Yan S; Zhang H; Xie Y; Sheng W; Xiang J; Ye Z; Chen W; Yang J
Cancer Invest; 2010 Jan; 28(1):85-93. PubMed ID: 19916746
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis inhibition by the maleimide-based small molecule GNX-686.
Nowak-Sliwinska P; Storto M; Cataudella T; Ballini JP; Gatz R; Giorgio M; van den Bergh H; Plyte S; Wagnières G
Microvasc Res; 2012 Mar; 83(2):105-10. PubMed ID: 22056402
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of lycopene on HMGB1-mediated pro-inflammatory responses in both cellular and animal models.
Lee W; Ku SK; Bae JW; Bae JS
Food Chem Toxicol; 2012 Jun; 50(6):1826-33. PubMed ID: 22429818
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of vascular endothelial growth factor-induced angiogenesis by scopoletin through interrupting the autophosphorylation of VEGF receptor 2 and its downstream signaling pathways.
Pan R; Dai Y; Gao XH; Lu D; Xia YF
Vascul Pharmacol; 2011; 54(1-2):18-28. PubMed ID: 21078410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]